Skip to main content
Clinical Trials/JPRN-UMIN000021783
JPRN-UMIN000021783
Unknown
Phase 1

A prospective study which assess the safety and efficiacy of haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide for adult T cell leukemia/lymphoma - Haplo for AT

ational Cancer Center Hospital0 sites17 target enrollmentApril 5, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
aggressive adult T cell leukemia/lymphoma
Sponsor
ational Cancer Center Hospital
Enrollment
17
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 5, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who meet any criteria below are ineligible (1\) severe organ failure (2\) uncontrolled hypertension (3\) HIV infection (4\) uncontrolled infection (5\) uncontrolled CNS invasion (6\) pregnant/lactating (7\) psychological disorder (8\) known allergy for drugs used as GVHD prophylaxis or conditioning regimen (9\) history of administration of anti\-CCR4 antibody (10\) high titer of anti\-donor specific HLA antibody (11\) the physician considers inappropriate for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials